Apimeds Pharmaceuticals US

Apimeds Pharmaceuticals US, Inc. is a clinical-stage biopharmaceutical company developing Apitox, an intradermal injection of bee venom toxin. The company aims to use it to treat inflammation and pain management symptoms associated with knee osteoarthritis. Apimeds Pharmaceuticals US primarily focuses on developing innovative therapies to address inflammation and pain management symptoms related to knee osteoarthritis (OA), and to a lesser extent, MS. Apitox is currently marketed and sold by Apimeds Inc. in Korea under the name "Apitoxin" for the treatment of OA.